top of page


FDA approves Sun Pharma Ilumya for adults with active psoriatic arthritis
The FDA has approved Sun Pharma's Ilumya for adults with active psoriatic arthritis, expanding the IL-23 inhibitor beyond its established plaque psoriasis indication.

nuaxia
Nov 22 min read


Sun Pharma licenses global rights to LIB Therapeutics' cholesterol drug lerodalcibep
The agreement gives Sun Pharma rights to the once-monthly PCSK9 inhibitor lerodalcibep across global markets excluding the US and China.

nuaxia
Sep 281 min read
bottom of page